-
Scurfin (FoxP3) controls T-dependent immune responses in vivo through regulation of CD4+ T cell effector function.
Journal of ImmunologyKasprowicz DJ, Smallwood PS, Tyznik AJ, Ziegler SF -
P53(110-124)-specific human CD4+ T-helper cells enhance in vitro generation and antitumor function of tumor-reactive CD8+ T cells.
Cancer ResChikamatsu K, Albers A, Stanson J, Kwok WW, Appella E, Whiteside TL, DeLeo AB -
Low-avidity recognition by CD4+ T cells directed to self-antigens.
European Journal of ImmunologyGebe JA, Falk BA, Rock KA, Kochik SA, Heninger AK, Reijonen H, Kwok WW, Nepom GT -
Conversations with GAD.
Journal of AutoimmunityNepom GT -
Guidelines for intervention trials in subjects with newly diagnosed type 1 diabetes.
DiabetesGreenbaum CJ, Harrison LC, Immunology of Diabetes Society. -
Use of HLA class II tetramers in tracking antigen-specific T cells and mapping T-cell epitopes.
MethodsReijonen H, Kwok WW -
Binding of outer surface protein A and human lymphocyte function-associated antigen 1 peptides to HLA-DR molecules associated with antibiotic treatment-resistant Lyme arthritis.
Arthritis and RheumatismSteere AC, Falk B, Drouin EE, Baxter-Lowe LA, Hammer J, Nepom GT -
Differential antigen sensitivity and costimulatory requirements in human Th1 and Th2 antigen-specific CD4+ cells with similar TCR avidity.
J ImmunolHolzer U, Kwok WW, Nepom GT, Buckner JH -
HLA tetramer-based artificial antigen-presenting cells for stimulation of CD4+ T cells.
Clin ImmunolMaus MV, Riley JL, Kwok WW, Nepom GT, June CH -
MHC multimers: expanding the clinical toolkit.
Clinical ImmunologyNepom GT -
Challenges in staining T cells using HLA class II tetramers.
Clin ImmunolKwok WW -
Therapy of autoimmune diseases: clinical trials and new biologics.
Current Opinion in ImmunologyNepom GT -
Magnitude of the inflammatory response to cardiopulmonary bypass and its relation to adverse clinical outcomes.
Inflammation ResearchHolmes JH 4th, Connolly NC, Paull DL, Hill ME, Guyton SW, Ziegler SF, Hall RA -
Macrophages from high-risk HLA-DQB1*0201/*0302 type 1 diabetes mellitus patients are hypersensitive to lipopolysaccharide stimulation.
Scand J ImmunolPlesner A, Greenbaum CJ, Gaur LK, Ernst RK, Lernmark A -
Use of class II tetramers for identification of CD4+ T cells.
Journal of Immunological MethodsKwok WW, Ptacek NA, Liu AW, Buckner JH
